Table II.
Baseline of clinical characteristics between patients with glioma with and without radiotherapy during the first operation.
| Radiotherapy | |||
|---|---|---|---|
| Characteristics | No | Yes | P-value |
| Mean age ± SD, years | 42.76±13.80 | 42.98±13.22 | 0.944 |
| Sex, n (%) | 0.227 | ||
| Male | 13 (16.25) | 30 (37.50) | |
| Female | 16 (20.00) | 21 (26.25) | |
| Location of tumor [n (%)] | 0.216a | ||
| Frontal lobe | 15 (18.75) | 29 (36.25) | |
| Temporal lobe | 4 (5.00) | 13 (16.25) | |
| Parietal lobe | 4 (5.00) | 4 (5.00) | |
| Occipital lobe | 1 (1.25) | 3 (3.75) | |
| Others | 5 (6.25) | 2 (2.50) | |
| Grade [n (%)] | 0.148a | ||
| I | 3 (3.75) | 4 (5.00) | |
| II | 13 (16.25) | 11 (13.75) | |
| III | 4 (5.00) | 12 (15.00) | |
| IV | 9 (11.25) | 24 (30.00) | |
| Expression of CCL2, n (%) | 0.472 | ||
| Negative | 12 (15.00) | 17 (21.25) | |
| Positive | 17 (21.25) | 34 (42.50) | |
| Expression of CCR2, n (%) | |||
| Negative | 13 (16.25) | 28 (35.00) | 0.386 |
| Positive | 16 (20.00) | 23 (28.75) | |
aR x C contingency table χ2 test for grade and location.